| Literature DB >> 32358195 |
Mark P Jedrychowski1,2, Gina Z Lu3,2, John Szpyt2, Marco Mariotti4, Ryan Garrity3,2, Joao A Paulo2, Devin K Schweppe2, Dina Laznik-Bogoslavski3,2, Lawrence Kazak3,2, Michael P Murphy5,6, Vadim N Gladyshev4, Steven P Gygi2, Edward T Chouchani1,2, Bruce M Spiegelman1,2.
Abstract
Oxidation of cysteine thiols by physiological reactive oxygen species (ROS) initiates thermogenesis in brown and beige adipose tissues. Cellular selenocysteines, where sulfur is replaced with selenium, exhibit enhanced reactivity with ROS. Despite their critical roles in physiology, methods for broad and direct detection of proteogenic selenocysteines are limited. Here we developed a mass spectrometric method to interrogate incorporation of selenium into proteins. Unexpectedly, this approach revealed facultative incorporation of selenium as selenocysteine or selenomethionine into proteins that lack canonical encoding for selenocysteine. Selenium was selectively incorporated into regulatory sites on key metabolic proteins, including as selenocysteine-replacing cysteine at position 253 in uncoupling protein 1 (UCP1). This facultative utilization of selenium was initiated by increasing cellular levels of organic, but not inorganic, forms of selenium. Remarkably, dietary selenium supplementation elevated facultative incorporation into UCP1, elevated energy expenditure through thermogenic adipose tissue, and protected against obesity. Together, these findings reveal the existence of facultative protein selenation, which correlates with impacts on thermogenic adipocyte function and presumably other biological processes as well.Entities:
Keywords: ROS; brown adipose tissue; cysteine; selenocysteine
Mesh:
Substances:
Year: 2020 PMID: 32358195 PMCID: PMC7245117 DOI: 10.1073/pnas.2001387117
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Fig. 1.Selenocysteine incorporation into 253 locus of UCP1. (A) MS1 spectrum of UCP1 tryptic peptide spanning position 253 with a mass shift corresponding to the exact mass difference between cysteine and selenocysteine. This peptide is +3, so the m/z shift indicates a mass difference of 47.94 Da. (B) MS criteria for identification of a facultative selenocysteine site; (Top) presence of MS1 selenium isotope signature; (Middle) mass shift corresponding to addition of selenocysteine derivatization agents; (Bottom) fragment mass spectrum localizing selenium mass to cysteine locus. (C) Presence of selenium stable isotope signature on mass-shifted UCP1 peptide spanning position 253. Colors indicate peaks matching the stable isotope signature of selenium shown in B. (D) Fragment spectrum of UCP1 peptide localizing the mass difference between sulfur and selenium to position 253. (E) Presence of selenium stable isotope signature on methionine-oxidized form of mass-shifted UCP1 peptide spanning position 253. Colors indicate peaks matching the stable isotope signature of selenium shown in B. (F) Fragment spectrum of UCP1 methionine-oxidized peptide localizing the mass difference between sulfur and selenium to position 253. (G) Fragment spectrum of synthetic AQUA peptide with selenocysteine at position 253.
Fig. 2.Characterization of selenocysteine incorporation into the UCP1 253 locus. (A) Proportion of selenocysteine 253 form of UCP1 estimated using internal standard AQUA peptides. (B) Relative abundance of selenenic acid and sulfenic acid forms of UCP1; n = 3. (C) Autoradiogram of WT and UCP1KO brown adipocyte lysates treated with sodium 75Se-selenite throughout differentiation. Prominent band in the 20- to 25-kDa region indicates well-established GPx selenoprotein family. No observable signal in the molecular weight (MW) region of UCP1 (∼33 kDa). (D) Relative changes in content of the selenocysteine form of UCP1 in brown adipocytes treated with sodium selenite; n = 3. (E) Relative changes in content of the selenocysteine form of UCP1 in brown adipocytes treated with selenomethionine; n = 3. (F) Relative changes in content of the selenocysteine form of UCP1 in brown adipocytes treated with selenocysteine (SeCys); n = 3.
Fig. 3.Dietary selenium differentially modifies canonical and facultative selenation of proteins. (A) Expression of canonical selenoproteins mapped in this study of BAT and modulated by 0.1- to 0.4-ppm dietary sodium selenite; n = 5. (B) Identification of selective facultative selenocysteine insertion into BAT metabolic proteins; n = 5. (C) Identification of selective facultative selenomethionine insertion into BAT metabolic proteins; n = 5. (D) Identification of selective facultative selenomethionine and selenocysteine insertion into s.c. white adipose tissue proteins; n = 5. (E) 2.25-ppm dietary selenium increases the amount of Sec253 UCP1; n = 5.
Fig. 4.Elevated dietary selenium enhances BAT energy expenditure and protects against obesogenesis induced by high-fat feeding. (A) Weight of mice prior to intervention with defined selenium-containing chow diets; n = 24 to 25. (B) Weight gain of mice on chow diets containing defined selenium concentrations; n = 24 to 25. (C) Cumulative food intake of mice on chow diets containing defined selenium concentrations; n = 24 to 25. (D) Whole-body oxygen consumption upon acute 1-mg/kg CL of mice following 8 wk on chow diets containing defined selenium concentrations; n = 7. (E) Whole-body CO2 release upon acute 1-mg/kg CL of mice following 8 wk on chow diets containing defined selenium concentrations; n = 7. (F) Whole-body respiratory exchange quotient (RER) upon acute 1-mg/kg CL of mice following 8 wk on chow diets containing defined selenium concentrations; n = 7. (G) Weight of mice prior to intervention with defined selenium-containing HFD; n = 12 to 15. (H) Weight gain of mice on HFD containing 0.1- or 2.25-ppm sodium selenite; n = 12 to 15. (I) Whole-body composition of mice following 8 wk HFD containing either 0.1- or 2.25-ppm sodium selenite; n = 12 to 15. (J) Cumulative food intake of mice on HFD containing either 0.1- or 2.25-ppm sodium selenite; n = 12 to 15. (K) Liver fibrosis and inflammation markers of mice on HFD containing either 0.1- or 2.25-ppm sodium selenite; n = 4.